Keryx Biopharmaceuticals (MM)
   
To register click here

Keryx Biopharmaceuticals Stock Price KERX

Company Description : A biopharmaceutical company, focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. url: www.keryx.com

Name:
Keryx Biopharmaceuticals (MM)
Symbol:
NASDAQ:KERX
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.020.872.311.972.352.342.252.3441118219:51:04
To register Click hereRegister for free Keryx Biopharmaceuticals stock prices.

Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference : Presentation Scheduled for Wednesday, December 2nd at 10:30AM ET NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that Ron Bentsur, the Company's Chief Executive...

Free Keryx Biopharmaceuticals Stock Charts

Keryx Biopharmaceuticals Historical Stock Chart
Keryx Biopharmaceuticals Historical Stock Chart
Keryx Biopharmaceuticals Monthly Stock Chart
Keryx Biopharmaceuticals Monthly Stock Chart
Keryx Biopharmaceuticals Intraday stock chart
Keryx Biopharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Keryx Biopharmaceuticals stock Price, quotes, trades and FREE Keryx Biopharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Keryx Biopharmaceuticals (KERX) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Keryx Biopharmaceuticals News & Message Board Discussion

Latest Keryx Biopharmaceuticals News Headlines
DateTimeSource
Headline
11/24/20098:30AMPRNUSKeryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
11/11/20098:30AMPRNUSKeryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annua
11/09/20094:30PMPRNUSKeryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
11/06/20098:30AMPRNUSKeryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at
11/04/20098:30AMPRNUSKeryx Biopharmaceuticals to Present at the Merriman Curhan Ford 6th Annual Investor Summit
10/29/20098:30AMPRNUSKeryx Biopharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
10/26/20098:30AMPRNUSKeryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphos
10/08/20098:30AMPRNUSPhase 2 Study of KRX-0401 (Perifosine) in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma Open
09/29/20098:00AMPRNUSUpdated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Carcinoma Reported
09/25/20095:25PMPRNUSKeryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered Direct Offering
09/23/20098:30AMPRNUSKeryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the
Latest Message Board Discussions
DateTime
TitleMore
11/23/200912:19AM3Q very good data:25M revenue,15M NI, EPS:0.32; time
11/06/20092:14PMThanks Gordo I'll do that
11/05/20093:13PMLooks like a little bit of life in
10/29/20093:41PMKeryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of
10/29/20093:21PMKeryx Biopharmaceuticals to Present at the Oppenheimer 20th
10/28/20093:06PMMany stocks have computer based crap going on.
10/28/20092:53PMLOL: Day''s Range [b]1.82[/b] - 2.07[/b]
10/22/20092:25PM$2.15 today lower than its latest offer @2.50..
10/08/20093:24PM**Recent Offering proceeds are to be used for
10/03/20095:20PMKerx website: PIPELINE

Keryx Biopharmaceuticals Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Keryx Biopharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Keryx Biopharmaceuticals Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  1147 2.31 11/24/2009 4:00PM USD


 



s Stock Prices supplied by NASDAQ.
Free NASDAQ stock prices are delayed by at least s minutes. Realtime NASDAQ stock prices available.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
41 site:2us nasdaq kerx091124 22:52 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )